Cubist Systematic Strategies, LLC Ligand Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $1.84 Million - $2.16 Million	-28,005 Reduced 54.75%	23,149 $1.7 Million
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $2.54 Million - $3.99 Million	41,232 Added 415.56%	51,154 $3.42 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $78 - $844,883	-7,855 Reduced 44.19%	9,922 $854,000
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $397,191 - $623,929	5,330 Added 42.82%	17,777 $1.59 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $886,351 - $1.41 Million	9,331 Added 299.45%	12,447 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $128,966 - $167,508	1,010 Added 47.96%	3,116 $481,000
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $379,439 - $536,658	-3,708 Reduced 63.78%	2,106 $293,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $1.53 Million - $2.11 Million	-13,535 Reduced 69.95%	5,814 $763,000
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $569,154 - $1.23 Million	-5,719 Reduced 22.81%	19,349 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $1.4 Million - $1.85 Million	17,419 Added 227.73%	25,068 $2.49 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $488,460 - $691,130	-5,454 Reduced 41.62%	7,649 $729,000
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $855,343 - $1.55 Million	-12,527 Reduced 48.88%	13,103 $1.47 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $1.49 Million - $2.53 Million	23,475 Added 1089.33%	25,630 $1.86 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $4.42 Million - $5.18 Million	-45,593 Reduced 95.49%	2,155 $225,000
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $1.72 Million - $2.4 Million	19,950 Added 71.77%	47,748 $4.75 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $751,874 - $905,638	7,002 Added 33.67%	27,798 $3.17 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $1.4 Million - $1.88 Million	13,193 Added 173.52%	20,796 $2.61 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $975,921 - $2.07 Million	7,603 New	7,603 $1.03 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account